Both the PHS Clinical Practice Guideline and the Guide to Community
Preventive Services identified many future research questions pertaining
to successful treatment of tobacco dependence that, if answered,
could dramatically improve cessation rates and reduce health disparities
due to tobacco use. The PHS Clinical Practice Guideline suggests
that research should focus on the development of effective interventions
and delivery strategies for populations that carry a disproportionate
burden from tobacco (e.g., adolescents; pregnant smokers; American
Indians and Alaska Natives; individuals with low SES/limited educational
attainment; individuals with psychiatric disorders, including substance
use disorders). Featured Partner Activity
NTCC partner National Institute on Drug Abuse
(NIDA) is focused on research in a variety of topic areas to advances
in the reach, effectiveness and adoption of tobacco cessation
interventions across both individuals and populations. Current
NIDA areas of interest include pharmacogenetics, genes/environment
interactions, and behavioral and integrative treatment development.
In addition to their existing research agenda,
NIDA has received additional funding as part of the American Recovery
and Reinvestment Act (ARRA) of 2009. ARRA provided NIDA with $10.4
B for 2 years, including $8.2 B in support of scientific research
priorities, $300 M shared instrumentation and equipment, and $400
M Comparative Effectiveness Research. These include:
- Challenge Grants provide RC1 $200M using RC1 mechanism. Topics
include behavior, behavioral change, and prevention; biomarker
discovery and validation; clinical research, comparative effectiveness
research (CER); genomics; health disparities; information technology
for processing health care data; and translational science.
http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-09-003.html
- Research and Research Infrastructure "Grand Opportunities"
(aka GO Grants) provide $200M using RC2 mechanism. This supports
high impact ideas that lend themselves to short-term funding,
and may lay the foundation for new fields of investigation.
Topics include: vaccines and immunotherapies, brain development
and genetics, biomarkers and phenotypes and environment. http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-09-004.html
- Biomedical Research Core Centers to Enhance Research Resources
allocates $100 M using P30 mechanism to provide institutional
awards for support of shared resources. http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-09-005.html
Other Partner Activities
NTCC partners are currently conducting many
activities related to this priority. For a list of these NTCC
partner activities, click here.
|
